Exploring Psychedelic Therapies
These educational infographics are designed to provide accessible, research-informed overviews of several substances currently being studied or discussed within psychedelic and mental health care. Each guide summarizes the history, pharmacology, subjective effects, potential risks, and current therapeutic interest surrounding these compounds.
While some of these substances are being explored in clinical and academic settings, many remain federally restricted or are not approved for general medical use. This information is intended for educational purposes only and should not be interpreted as medical advice, endorsement, or encouragement of unsupervised use.
Ayahuasca
Ayahuasca is a traditional psychoactive brew originating from Indigenous cultures of the Amazon basin, where it has been used ceremonially and spiritually for generations. It is typically made by combining plants containing DMT with a vine that contains MAO inhibitors, allowing the psychoactive compounds to become orally active.
In modern discussions, ayahuasca is often associated with deep introspection, emotional processing, and spiritual experiences, though it can also produce intense physical and psychological effects. Research into its therapeutic potential is ongoing, particularly in areas related to depression, trauma, and addiction.
Ibogaine
Ibogaine is a naturally occurring psychoactive compound derived from the root bark of the African iboga shrub, traditionally used in spiritual and initiation ceremonies in parts of Central West Africa.
In recent decades, ibogaine has gained attention for its potential role in interrupting opioid and substance use disorders, though research remains limited and its use carries significant medical risks. The experience is often described as long-lasting, introspective, and physically demanding. Due to concerns involving heart rhythm complications and other serious side effects, ibogaine treatment requires careful medical screening and supervision.
.jpg)
Ketamine
Ketamine is a dissociative anesthetic that has been used in medical settings for decades and more recently has gained attention for its rapid antidepressant effects. Unlike classic psychedelics, ketamine works primarily through NMDA receptor modulation and can produce altered states involving dissociation, detachment, and changes in perception.
In controlled clinical settings, ketamine-assisted therapy is being explored for treatment-resistant depression, PTSD, and other mental health conditions. While it may provide rapid symptom relief for some individuals, ketamine also carries risks related to blood pressure, cognition, dependency, and misuse.
LSD
LSD, short for lysergic acid diethylamide, is a powerful psychedelic compound first synthesized in 1938 by Swiss chemist Albert Hofmann. Known for producing profound alterations in perception, thought patterns, and sensory experience, LSD became widely associated with psychological research and countercultural movements during the 1950s and 1960s.
Modern scientific interest has returned in recent years, with researchers exploring its potential therapeutic applications for anxiety, depression, addiction, and end-of-life distress. LSD experiences can vary dramatically depending on dosage, mindset, environment, and individual mental health history.
MDMA
MDMA, commonly known as ecstasy or molly, is a psychoactive compound that produces stimulant and empathogenic effects, often increasing feelings of emotional openness, connection, and empathy. Unlike traditional psychedelics, MDMA primarily affects serotonin, dopamine, and norepinephrine systems rather than producing strong visual hallucinations.
In recent years, MDMA-assisted therapy has shown promising results in clinical trials focused on PTSD and trauma-related conditions. While many participants report meaningful emotional breakthroughs, MDMA also carries risks including elevated heart rate, dehydration, overheating, mood changes, and potential neurotoxicity with repeated misuse.
Mescaline
Mescaline is a naturally occurring psychedelic compound found in several cactus species, including peyote and San Pedro. It has been used ceremonially by Indigenous cultures in the Americas for centuries as part of spiritual and healing practices. Mescaline experiences are often described as emotionally reflective, sensory-enhancing, and deeply connected to nature and symbolism.
Although it has received less modern research attention than compounds like psilocybin or LSD, interest in mescaline has grown alongside broader psychedelic research efforts. Effects can last many hours and may include nausea, changes in perception, and intense emotional experiences.
Psilocybin
Psilocybin is a naturally occurring psychedelic compound found in certain species of mushrooms, often referred to as "magic mushrooms." Once ingested, psilocybin is converted into psilocin, which interacts primarily with serotonin receptors in the brain.
​
Research over the past two decades has explored its potential therapeutic use in areas such as depression, anxiety, PTSD, addiction, and end-of-life distress. Many individuals describe psilocybin experiences as emotionally meaningful or spiritually significant, though effects can vary widely depending on dose, mindset, environment, and personal mental health history.
​
Psilocybin
Psilocybin is a naturally occurring psychedelic compound found in certain species of mushrooms, often referred to as “magic mushrooms.” Once ingested, psilocybin is converted into psilocin, which interacts primarily with serotonin receptors in the brain.
Research over the past two decades has explored its potential therapeutic use in areas such as depression, anxiety, PTSD, addiction, and end-of-life distress. Many individuals describe psilocybin experiences as emotionally meaningful or spiritually significant, though effects can vary widely depending on dose, mindset, environment, and personal mental health history.